| scholarly article | Q13442814 |
| P50 | author | Anthony H. Futerman | Q41388875 |
| Shifra Ben-Dor | Q41607461 | ||
| P2093 | author name string | Alfred H Merrill | |
| Shifra Ben-Dor | |||
| Abraham Nyska | |||
| Tamara Berkutzki | |||
| Elad L Laviad | |||
| Hyejung Park | |||
| Racheli Erez-Roman | |||
| Yael Pewzner-Jung | |||
| Shirley Horn-Saban | |||
| Ester Feldmesser | |||
| Ori Brenner | |||
| Michal Levy | |||
| Calanit Raanan | |||
| Oshrit Ben-David | |||
| Daniela Amann-Zalcenstein | |||
| Dorin Holzman | |||
| Svantje Braun | |||
| P2860 | cites work | (Dihydro)ceramide synthase 1 regulated sensitivity to cisplatin is associated with the activation of p38 mitogen-activated protein kinase and is abrogated by sphingosine kinase 1 | Q24337386 |
| KEGG: kyoto encyclopedia of genes and genomes | Q24515297 | ||
| From genomics to chemical genomics: new developments in KEGG | Q24538628 | ||
| Ceramide generated by sphingomyelin hydrolysis and the salvage pathway is involved in hypoxia/reoxygenation-induced Bax redistribution to mitochondria in NT-2 cells | Q24646847 | ||
| KEGG for linking genomes to life and the environment | Q24650347 | ||
| Roles of bioactive sphingolipids in cancer biology and therapeutics | Q24657499 | ||
| WebGestalt: an integrated system for exploring gene sets in various biological contexts | Q24813284 | ||
| An overview of rodent toxicities: liver and kidney effects of fumonisins and Fusarium moniliforme | Q24815242 | ||
| DAVID: Database for Annotation, Visualization, and Integrated Discovery | Q27499374 | ||
| Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources | Q27860739 | ||
| p21 is a universal inhibitor of cyclin kinases | Q28257305 | ||
| Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance | Q28291556 | ||
| Two mammalian longevity assurance gene (LAG1) family members, trh1 and trh4, regulate dihydroceramide synthesis using different fatty acyl-CoA donors | Q28509468 | ||
| Mitochondrial degeneration and not apoptosis is the primary cause of embryonic lethality in ceramide transfer protein mutant mice | Q28512884 | ||
| Serine palmitoyl-CoA transferase (SPT) deficiency and sphingolipid levels in mice | Q28592964 | ||
| BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis | Q28594183 | ||
| Sphingolipid functions in Saccharomyces cerevisiae | Q28679249 | ||
| The significance of digital gene expression profiles | Q29614357 | ||
| Adult ceramide synthase 2 (CERS2)-deficient mice exhibit myelin sheath defects, cerebellar degeneration, and hepatocarcinomas | Q30492014 | ||
| A vital role for glycosphingolipid synthesis during development and differentiation | Q30748450 | ||
| Ontologizer 2.0--a multifunctional tool for GO term enrichment analysis and data exploration | Q31156999 | ||
| BioVenn - a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams | Q33377261 | ||
| A critical role for ceramide synthase 2 in liver homeostasis: I. alterations in lipid metabolic pathways | Q33796283 | ||
| Implications of apoptosis for toxicity, carcinogenicity, and risk assessment: fumonisin B(1) as an example | Q34213849 | ||
| Defects in cell growth regulation by C18:0-ceramide and longevity assurance gene 1 in human head and neck squamous cell carcinomas | Q34341991 | ||
| Differential sensitivity of rat kidney and liver to fumonisin toxicity: organ-specific differences in toxin accumulation and sphingoid base metabolism | Q34513658 | ||
| When do Lasses (longevity assurance genes) become CerS (ceramide synthases)?: Insights into the regulation of ceramide synthesis | Q34541094 | ||
| Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate | Q34731468 | ||
| De novo N-palmitoylsphingosine synthesis is the major biochemical mechanism of ceramide accumulation following p53 up-regulation. | Q34768921 | ||
| Ceramide synthases and ceramide levels are increased in breast cancer tissue | Q34961114 | ||
| Not just a CDK inhibitor: regulation of transcription by p21(WAF1/CIP1/SDI1). | Q34995575 | ||
| Sphingolipidomics: high-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry | Q36127968 | ||
| Disruption of ceramide synthesis by CerS2 down-regulation leads to autophagy and the unfolded protein response. | Q36155852 | ||
| Lipid mediators of insulin resistance | Q36867145 | ||
| Sorafenib and vorinostat kill colon cancer cells by CD95-dependent and -independent mechanisms | Q37268127 | ||
| Role of very long fatty acid-containing glycosphingolipids in membrane organization and cell signaling: the model of lactosylceramide in neutrophils. | Q37328078 | ||
| Sumoylated PPARalpha mediates sex-specific gene repression and protects the liver from estrogen-induced toxicity in mice | Q37363062 | ||
| Role of human longevity assurance gene 1 and C18-ceramide in chemotherapy-induced cell death in human head and neck squamous cell carcinomas | Q40169778 | ||
| Mass spectrometric identification of increased C16 ceramide levels during apoptosis | Q40922788 | ||
| Characterization of cell-cycle arrest by fumonisin B1 in CV-1 cells | Q41008881 | ||
| Ceramide biogenesis is required for radiation-induced apoptosis in the germ line of C. elegans | Q42936816 | ||
| Analysis of sphingosine 1-phosphate, ceramides, and other bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry | Q43830323 | ||
| Comments on R. Karbe and R. L. Kerlin (2002). Cystic degeneration/spongiosis hepatis (Toxicol Pathol 30 (2), 216-227). | Q44704100 | ||
| Multiple adaptive mechanisms to chronic liver disease revealed at early stages of liver carcinogenesis in the Mdr2-knockout mice | Q45857462 | ||
| Classification of proliferative hepatocellular lesions in harlan sprague-dawley rats chronically exposed to dioxin-like compounds. | Q46417388 | ||
| The relationship among microsomal enzyme induction, liver weight and histological change in rat toxicology studies | Q47281524 | ||
| Fumonisins: fungal toxins that shed light on sphingolipid function | Q47986534 | ||
| Protection of C. elegans from anoxia by HYL-2 ceramide synthase | Q47995901 | ||
| Liver gene expression analysis reveals endoplasmic reticulum stress and metabolic dysfunction in SCD1-deficient mice fed a very low-fat diet. | Q50082945 | ||
| Toxicity of fumonisin B1 to B6C3F1 mice: a 14-day gavage study. | Q50908586 | ||
| Toxicology and carcinogenesis studies of fumonisin B1 (cas no. 116355-83-0) in F344/N rats and B6C3F1 mice (feed studies) | Q51540082 | ||
| Incretin receptors for glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide are essential for the sustained metabolic actions of vildagliptin in mice. | Q53532607 | ||
| Regulation of cyclin-dependent kinase inhibitor p21(WAF1/Cip1/Sdi1) gene expression in hepatic regeneration | Q73107788 | ||
| P433 | issue | 14 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell biology | Q7141 |
| ceramides | Q424213 | ||
| P304 | page(s) | 10911-23 | |
| P577 | publication date | 2010-04-02 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | A critical role for ceramide synthase 2 in liver homeostasis: II. insights into molecular changes leading to hepatopathy | |
| P478 | volume | 285 |
| Q61800935 | 3-ketodihydrosphingosine reductase mutation induces steatosis and hepatic injury in zebrafish |
| Q33796283 | A critical role for ceramide synthase 2 in liver homeostasis: I. alterations in lipid metabolic pathways |
| Q34215485 | A gene variant in CERS2 is associated with rate of increase in albuminuria in patients with diabetes from ONTARGET and TRANSCEND. |
| Q58488814 | A selective inhibitor of ceramide synthase 1 reveals a novel role in fat metabolism |
| Q36620822 | Ablation of ceramide synthase 2 causes chronic oxidative stress due to disruption of the mitochondrial respiratory chain |
| Q47157018 | Ablation of ceramide synthase 2 exacerbates dextran sodium sulphate-induced colitis in mice due to increased intestinal permeability. |
| Q35747763 | Ablation of ceramide synthase 2 strongly affects biophysical properties of membranes |
| Q53364131 | Ablation of very long acyl chain sphingolipids causes hepatic insulin resistance in mice due to altered detergent-resistant membranes. |
| Q91966157 | Acid Sphingomyelinase Deficiency Ameliorates Farber Disease |
| Q47595409 | Adoptive Transfer of Ceramide Synthase 6 Deficient Splenocytes Reduces the Development of Colitis. |
| Q37357098 | Altering the sphingolipid acyl chain composition prevents LPS/GLN-mediated hepatic failure in mice by disrupting TNFR1 internalization |
| Q91194967 | Associations of plasma very-long-chain SFA and the metabolic syndrome in adults |
| Q28115515 | Autophagy regulates sphingolipid levels in the liver |
| Q92504639 | Biosynthesis of long chain base in sphingolipids in animals, plants and fungi |
| Q36002934 | Cardiomyocyte specific deficiency of serine palmitoyltransferase subunit 2 reduces ceramide but leads to cardiac dysfunction |
| Q51065188 | Cell-type-specific expression pattern of ceramide synthase 2 protein in mouse tissues. |
| Q40039682 | Central Modulation of Neuroinflammation by Neuropeptides and Energy-Sensing Hormones during Obesity |
| Q36727429 | Ceramide Synthase 5 Is Essential to Maintain C16:0-Ceramide Pools and Contributes to the Development of Diet-induced Obesity |
| Q28547365 | Ceramide as a mediator of non-alcoholic Fatty liver disease and associated atherosclerosis |
| Q42706090 | Ceramide in stem cell differentiation and embryo development: novel functions of a topological cell-signaling lipid and the concept of ceramide compartments |
| Q28384389 | Ceramide induced mitophagy and tumor suppression |
| Q43895216 | Ceramide synthase 2 deficiency aggravates AOM-DSS-induced colitis in mice: role of colon barrier integrity. |
| Q51137358 | Ceramide synthase 2 facilitates S1P-dependent egress of thymocytes into the circulation in mice. |
| Q41995354 | Ceramide synthases 2, 5, and 6 confer distinct roles in radiation-induced apoptosis in HeLa cells |
| Q24609859 | Ceramide synthases at the centre of sphingolipid metabolism and biology |
| Q38472485 | Ceramide synthases in mammalians, worms, and insects: emerging schemes |
| Q33703218 | Ceramide synthesis regulates T cell activity and GVHD development |
| Q26822419 | Ceramide-induced apoptosis in renal tubular cells: a role of mitochondria and sphingosine-1-phoshate |
| Q38067062 | Ceramide-orchestrated signalling in cancer cells. |
| Q38833111 | Compounds of the sphingomyelin-ceramide-glycosphingolipid pathways as secondary messenger molecules: new targets for novel therapies for fatty liver disease and insulin resistance |
| Q47132347 | Critical Role for Very-Long Chain Sphingolipids in Invariant Natural Killer T Cell Development and Homeostasis. |
| Q38880061 | Defective ceramide synthases in mice cause reduced amplitudes in electroretinograms and altered sphingolipid composition in retina and cornea |
| Q41625711 | Development of pheochromocytoma in ceramide synthase 2 null mice |
| Q92091772 | Dietary fats and cardiometabolic disease: mechanisms and effects on risk factors and outcomes |
| Q43076641 | Direct interaction, instrumental for signaling processes, between LacCer and Lyn in the lipid rafts of neutrophil-like cells. |
| Q52615756 | Disruption of the ceramide synthase LOH1 causes spontaneous cell death in Arabidopsis thaliana. |
| Q35006514 | Distribution and functions of sterols and sphingolipids |
| Q52568791 | Does This Schlank Make Me Look Fat? |
| Q34138890 | Dual functions of the trans-2-enoyl-CoA reductase TER in the sphingosine 1-phosphate metabolic pathway and in fatty acid elongation |
| Q24302388 | ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid synthesis |
| Q88931642 | Eating as a motivated behavior: modulatory effect of high fat diets on energy homeostasis, reward processing and neuroinflammation |
| Q35314176 | Encephalopathy caused by ablation of very long acyl chain ceramide synthesis may be largely due to reduced galactosylceramide levels |
| Q35860939 | Expression of Ceramide Synthase 6 Transcriptionally Activates Acid Ceramidase in a c-Jun N-terminal Kinase (JNK)-dependent Manner |
| Q92146145 | Expression of the SNAI2 transcriptional repressor is regulated by C16-ceramide |
| Q38553917 | Genome-wide studies to identify risk factors for kidney disease with a focus on patients with diabetes |
| Q64360090 | Glucosylceramidase Maintains Influenza Virus Infection by Regulating Endocytosis |
| Q36405917 | Glycosphingolipids and cell death: one aim, many ways |
| Q35522279 | Hepatic fatty acid uptake is regulated by the sphingolipid acyl chain length. |
| Q92667796 | Hepatic pathology and altered gene transcription in a murine model of acid ceramidase deficiency |
| Q91062570 | Hepatic triglyceride accumulation via endoplasmic reticulum stress-induced SREBP-1 activation is regulated by ceramide synthases |
| Q89868169 | Histologic Lesions of Porto-Sinusoidal Vascular Disease Following Phlebotomy in Hemochromatosis |
| Q38241672 | Human genetic disorders of sphingolipid biosynthesis |
| Q48270370 | Identification and expression analysis of the zebrafish homologs of the ceramide synthase gene family |
| Q42622589 | Inactivation of ceramide synthase 6 in mice results in an altered sphingolipid metabolism and behavioral abnormalities |
| Q88137482 | Increased liver tumor formation in neutral sphingomyelinase-2-deficient mice |
| Q35931476 | It's a lipid's world: bioactive lipid metabolism and signaling in neural stem cell differentiation |
| Q40727621 | LPS-mediated septic shock is augmented in ceramide synthase 2 null mice due to elevated activity of TNFα-converting enzyme. |
| Q46664427 | Lactational changes in concentration and distribution of ganglioside molecular species in human breast milk from Chinese mothers. |
| Q24633453 | Mammalian ceramide synthases |
| Q34416437 | Metabolism of very long-chain Fatty acids: genes and pathophysiology |
| Q34117684 | Nanotube action between human mesothelial cells reveals novel aspects of inflammatory responses |
| Q46847888 | New insights into the organ-specific adverse effects of fumonisin B1: comparison between lung and liver |
| Q42709547 | Nodular regenerative hyperplasia: evolving concepts on underdiagnosed cause of portal hypertension |
| Q27315147 | Nogo-B regulates endothelial sphingolipid homeostasis to control vascular function and blood pressure |
| Q27012927 | On the future of mass-spectrometry-based lipidomics |
| Q38916409 | Oxidative stress elicited by modifying the ceramide acyl chain length reduces the rate of clathrin-mediated endocytosis |
| Q40700090 | Persistence of HCV in Acutely-Infected Patients Depletes C24-Ceramide and Upregulates Sphingosine and Sphinganine Serum Levels |
| Q37705582 | Pharmacogenetics of resistance to Cisplatin and other anticancer drugs and the role of sphingolipid metabolism |
| Q35537840 | Plasma phospholipid very-long-chain saturated fatty acids and incident diabetes in older adults: the Cardiovascular Health Study |
| Q37312126 | Protection of a ceramide synthase 2 null mouse from drug-induced liver injury: role of gap junction dysfunction and connexin 32 mislocalization |
| Q33649823 | Re-configuration of sphingolipid metabolism by oncogenic transformation |
| Q34418788 | Reduced ceramide synthase 2 activity causes progressive myoclonic epilepsy |
| Q35286905 | Renal sulfatides: sphingoid base-dependent localization and region-specific compensation of CerS2-dysfunction. |
| Q37377548 | Role of Intracellular Lipid Logistics in the Preferential Usage of Very Long Chain-Ceramides in Glucosylceramide |
| Q61444646 | Role of ceramide synthase 2 in G-CSF signaling and G-CSF-R translocation into detergent-resistant membranes |
| Q90341495 | Roles of Ceramides and Other Sphingolipids in Immune Cell Function and Inflammation |
| Q42183231 | Self-segregation of myelin membrane lipids in model membranes |
| Q35780081 | Serum Sphingolipid Variations Associate with Hepatic Decompensation and Survival in Patients with Cirrhosis |
| Q93050481 | Serum sphingolipid level in psoriatic patients with obesity |
| Q37109693 | Serum sphingolipidomic analyses reveal an upregulation of C16-ceramide and sphingosine-1-phosphate in hepatocellular carcinoma |
| Q35324757 | Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics |
| Q37808219 | Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance |
| Q37802552 | Sphingolipids and expression regulation of genes in cancer. |
| Q38332040 | Sphingolipids and mitochondrial apoptosis |
| Q33853998 | Sphingosine kinase 1 in cancer |
| Q39320764 | Sphingosine metabolism as a therapeutic target in cutaneous melanoma. |
| Q50421705 | T-cell egress from the thymus: Should I stay or should I go? |
| Q38695571 | The 3-hydroxyacyl-CoA dehydratases HACD1 and HACD2 exhibit functional redundancy and are active in a wide range of fatty acid elongation pathways. |
| Q35919682 | The Impact of Ischemia/Reperfusion Injury on Liver Allografts from Deceased after Cardiac Death versus Deceased after Brain Death Donors |
| Q26823045 | The complexity of sphingolipid biosynthesis in the endoplasmic reticulum |
| Q89723337 | The role of ceramides in metabolic disorders: when size and localization matters |
| Q39420607 | Therapeutic implications of bioactive sphingolipids: A focus on colorectal cancer |
| Q47681263 | Tumor suppressor p53 links ceramide metabolism to DNA damage response through alkaline ceramidase 2. |
| Q41687237 | Variations in serum sphingolipid levels associate with liver fibrosis progression and poor treatment outcome in hepatitis C virus but not hepatitis B virus infection |
| Q37805092 | p53 and regulation of bioactive sphingolipids |
Search more.